Wealthy Indians seek gray market blockbuster weight-loss drugs due to global supply shortages.
Wealthy Indians are turning to the gray market to secure blockbuster weight-loss drugs like Novo Nordisk's Ozempic and Eli Lilly's Mounjaro, as global supply shortages delay their availability in India. Stashing boxes in carry-on luggage, buying counterfeit formulas online, and importing from Europe are among the creative lengths taken by this obese population, with the anti-obesity medication market expected to reach $100 billion by 2030.
June 19, 2024
5 Articles